Faculty

Alison Fohner

Associate Professor, Epidemiology
Director of Institute of Public Health Genetics, Epidemiology


Education

PhD Public Health Genetics, University of Washington, 2015
MS Biology, Stanford University, 2008

Contact


Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 874B
Seattle, WA 98195

Bio

Dr. Fohner is a genetic epidemiologist applying innovative big data methods to extensive electronic health record, population-based longitudinal cohort, and multi-omic data to improve precision medicine. She approaches genetic epidemiology through an ELSI (ethical, legal, social implications) lens, and aims to promote equity and justice in the benefit of and access to genetic information in health settings. She prioritizes interdisciplinary collaborations and is a member of the Cardiovascular Health Research Unit at UW, where she integrates genomics and proteomics to identify early biomarkers for cognitive decline and dementia. She is an Associate Director of the Institute for Public Health Genetics, an interdisciplinary program in the School of Public Health that explores the application of genomics in public health, and is an adjunct investigator at Kaiser Permanente Northern California Division of Research. 

Research Interests

Dr. Fohner is a genetic epidemiologist applying innovative big data methods to extensive electronic health record and genomic data to improve precision medicine. She approaches genetic epidemiology through an ELSI (ethical, legal, social implications) lens, and aims to promote equity and justice in the benefit of and access to genetic information in health settings. She teaches in the Institute of Public Health Genetics, an interdisciplinary program in the School of Public Health that explores the application of genomics in public health, and is an adjunct investigator at Kaiser Permanente Northern California Division of Research.

Recent Publications (PubMed)

The Association Between APOE Genotype, Race, and Dementia: An Analysis of 7 Population-Based Cohort Studies.
(2026 Aug)
Neurol Genet 12(4): e200417
Lakomski N, Giorgio K, Stephen J, Mansolf M, Soumaré A, Gross AL, Aiello AE, Singh-Manoux A, Ikram MA, Helmer C, Satizabal CL, Levine DA, Lloyd-Jones DM, Briceño EM, Sorond FA, Wolters FJ, Himali JJ, Launer LJ, Mbangdadji D, Li D, Zhao L, Lopez OL, Debette S, Seshadri S, Judd SE, Hughes TM, Guðnason V, Griswold M, de Vries PS, Fohner A, Lutsey PL, Zmora R, Peterson EA, Scholtens D, Allen NB, Sedaghat S

Polygenic Risk Scores for Incident Dementia in the Multi-Ethnic Study of Atherosclerosis.
(2026 Jul)
Genet Epidemiol 50(5): e70046
Xue D, Blue EE, Sofer T, Hughes TM, Rotter JI, Post WS, Fohner AE

Exclusion by design: enrollment criteria limit older adult participation in SARS-CoV-2 vaccine clinical trials.
(2026 May 24)
J Clin Epidemiol 197(): 112343
Johnson TN, Chu HY, Fohner AE

Whole genome sequencing analysis of over 3500 individuals dementia-free over 85 years old.
(2026 Jun)
J Alzheimers Dis 111(4): 1772-1782
Peloso GM, Wang D, Abbruzzese SM, Bis JC, Choi SH, Beiser A, Bressler J, Dupuis J, Fohner AE, Ghanbari M, Gibbs RA, Heard-Costa N, Ikram MA, Lacaze P, Le Grand Q, Lopez OL, Mosley TH, Riaz M, Soumaré A, Yaqub A, Boerwinkle E, Psaty BM, Fornage M, TOPMed Neurocognitive Working Group, The Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer’s Disease Sequencing Project, Seshadri S, DeStefano AL

Integrating contextual determinants and polygenic risk to examine dementia and late-life cognition in the Multi-Ethnic Study of Atherosclerosis.
(2026 Apr)
Alzheimers Dement 22(4): e71384
Xue D, Hirsch JA, Besser L, Hughes TM, Blue EE, Fitzpatrick AL, Fohner AE

Show complete publication list

In the News

No news articles at this time.